| 000 | 01640 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514221945.0 | ||
| 264 | 0 | _c20050503 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm049559q _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVerschueren, Wim G | |
| 245 | 0 | 0 |
_aDesign and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cMar 2005 |
||
| 300 |
_a1930-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-HIV Agents _xchemical synthesis |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aHIV Integrase _xchemistry |
| 650 | 0 | 4 |
_aHIV Integrase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aHeterocyclic Compounds, 3-Ring _xchemical synthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 |
_aPhthalimides _xchemical synthesis |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aPyrroles _xchemical synthesis |
| 650 | 0 | 4 |
_aQuinoxalines _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aDierynck, Inge | |
| 700 | 1 | _aAmssoms, Katie I E | |
| 700 | 1 | _aHu, Lili | |
| 700 | 1 | _aBoonants, Paul M J G | |
| 700 | 1 | _aPille, Geert M E | |
| 700 | 1 | _aDaeyaert, Frits F D | |
| 700 | 1 | _aHertogs, Kurt | |
| 700 | 1 | _aSurleraux, Dominique L N G | |
| 700 | 1 | _aWigerinck, Piet B T P | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 48 _gno. 6 _gp. 1930-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm049559q _zAvailable from publisher's website |
| 999 |
_c15443834 _d15443834 |
||